(Original title: Zur Misteltherapie der Non-Hodgkin-Lymphome. Der Merkurstab 1994; 47:629. English by A. R. Meuss, FIL, MTA.)

We have reason to point out the following. It is occasionally said - not only by well-established opponents of mistletoe therapy but also by its so-called followers - that the use of mistletoe for non-Hodgkin's lymphoma is "contraindicated," "questionable," "requiring caution," "not without risk," "not the right thing," "might rouse sleeping dogs" and so on.

Such statements must be opposed. Many years of experience with cancer patients enable us to say that mistletoe therapy presents no problems and may be used to good effect to treat malignant lymphoma - following the usual initial chemotherapy. Moreover, the most intensive form of mistletoe therapy, combined infusion, is clearly effective in treating non-Hodgkin's lymphoma, and none of the above applies. If statements such as these prevent people who are considering mistletoe therapy from using it, their destiny may take an unnecessarily tragic course. Non-Hodgkin's lymphoma and mistletoe therapy are not mutually exclusive; on the contrary, mistletoe therapy is an excellent method of stabilizing a remission.

Bruno Emme, MD
Gesellschaft fuer Tumortherapie
Paulinenallee 32
D-20259 Hamburg, Germany